Table: Kaken Pharmaceutical -9-MTH group results

KAKEN PHARMACEUTICAL

06/02/2017 04:30

Feb 6 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             78.97               85.43           106.10     
                 (-7.6 pct)          (+20.1 pct)      (-3.3 pct)   
  Operating         24.95               29.69            28.90     
                 (-16.0 pct)         (+78.7 pct)      (-17.8 pct)  
  Recurring         25.23               29.92            29.10     
                 (-15.7 pct)         (+81.6 pct)      (-17.7 pct)  
  Net               17.98               20.13            20.80     
                 (-10.7 pct)        (+109.6 pct)      (-1.6 pct)   
  EPS            437.85 yen          486.14 yen       508.91 yen   
  Ann Div                                             150.00 yen   
  -Q2 div         75.00 yen           34.00 yen                    
  -Q4 div                             78.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T 
  ((Tokyo Headline News Desk +813 6441 1812))